Why the study?
Does the novel renin inhibitor SR 42128 reduce blood pressure and inhibit plasma renin activity in sodium-depleted monkeys?
Population
In vitro human and primate plasma renin, and in vivo sodium-depleted conscious monkeys
Design
Preclinical
Follow-up
3 hours
Authors
Loading...
Supports preclinical renin inhibitor validation; leaves open translation to human hypertension trials.
Does the novel renin inhibitor SR 42128 reduce blood pressure and inhibit plasma renin activity in sodium-depleted monkeys?
SR 42128 is a potent, long-acting renin inhibitor that effectively lowers blood pressure and inhibits plasma renin activity in primate models.
Clavière et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: